Clover Health Investments, Corp.

    Jurisdiction
    United States
    LEI
    5493000HLYOYQU6LK133
    ISIN
    US18914F1030 (CLOV)
    Sectors
    1. Healthcare
    2. Medical - Healthcare Plans

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. Read full profile

    Fundamentals

    Net revenue
    €1.37B
    Gross margin
    23.9%
    EBIT
    -€35.88M
    EBIT margin
    -2.6%
    Net income
    -€36.76M
    Net margin
    -2.7%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.07B +50.8% -€9.00M -75.5%
    €2.32B +12.2% €20.26M -325.1%
    €2.73B +17.7% -€2.13M -110.5%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Loengard Anna U N/A +27K $2.59 +$68.64K
    Garipalli Vivek N/A +447K $2.23 +$996.77K
    Reynoso Jamie L. CEO, Medicare Advantage -6.8K $2.89 -$19.72K
    Wai Conrad CEO, Counterpart Health -210K $3.30 -$692.33K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 11M $39.58M -42K Sell

    Earnings Calls

    Latest earnings call: May 7, 2024 (Q1 2024)

    Add to watchlist

    Notifications